Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

about

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q49912101

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@en

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@nl

type

Item

label

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@en

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@nl

prefLabel

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@en

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@nl

P1476

Microenvironment-induced CD44v ...... chronic lymphocytic leukemia.

@en

P2093

Christina Sternberg

http://www.w3.org/2001/XMLSchema#string

Daniela Asslaber

http://www.w3.org/2001/XMLSchema#string

Eva Szenes

http://www.w3.org/2001/XMLSchema#string

Lisa Tschech

http://www.w3.org/2001/XMLSchema#string

Michaela Schlederer

http://www.w3.org/2001/XMLSchema#string

Richard Greil

http://www.w3.org/2001/XMLSchema#string

Simone Roos

http://www.w3.org/2001/XMLSchema#string

Tamara Girbl

http://www.w3.org/2001/XMLSchema#string

Xiaobing Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

NF-kB inhibitor blocks B cell development at two checkpoints

Modulation of CD44 Activity by A6-Peptide

Genomic aberrations and survival in chronic lymphocytic leukemia

CD44 in cancer

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia

NF-kappaB in cancer: from innocent bystander to major culprit

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.

Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL

P304

1337-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-08-802462

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Julia Christine Gutjahr

Véronique Orian-Rousseau

P577

2018-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29352038

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5865232

http://www.w3.org/2001/XMLSchema#string